Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFranchise Brands Regulatory News (FRAN)

Share Price Information for Franchise Brands (FRAN)

Share Price is delayed by 15 minutes
Get Live Data
142.00    0.00 (0.00%)
Bid:
142.50
Ask:
147.50
Spread: 5.00 (3.509%)
Market Cap: £272.19m
FRAN Live PriceLast checked at - London Stock Exchange

Intraday Franchise Brands Share Chart

SHARE REPURCHASE PROGRAMME

4 Jan 2019 07:00

RNS Number : 1739M
Franchise Brands PLC
04 January 2019
 

4 January 2019

 

FRANCHISE BRANDS PLC

("Franchise Brands", "the Group" or "the Company")

 

SHARE REPURCHASE PROGRAMME

 

Franchise Brands announces that from today until 30 June 2019 it will commence a programme to purchase ordinary shares of 0.5 pence each ("Ordinary Shares") in the Company, up to a value of £200,000 (the "Programme"). This is a continuation of the programme that commenced in 2018 and saw the Company purchase 200,000 Ordinary Shares into Treasury.

As announced on 12 December 2018, the Group, which is cash generative, intends to continue the share repurchase programme to offset the dilutive impact of employee share option awards, focusing on overall shareholder return. Ordinary Shares purchased under the Programme will therefore be held in Treasury to enable the Company to meet obligations arising from share option programmes. The total number of Ordinary Shares currently outstanding under option arrangements is 4,533,530 representing 5.8 per cent. of the Company's issued share capital.

The Programme will be conducted by the Company in accordance with and under the terms of the general authority granted by the Company's shareholders at the Company's Annual General Meeting on 25 April 2018 to purchase up to 7,773,203 shares. This authority will expire at the end of the next Annual General Meeting of the Company in 2019 or, if earlier, at the close of business on 25 July 2019 ("2018 Authority").

The Company has entered into an agreement with its joint broker, Dowgate Capital Stockbrokers Limited, to carry out on-market purchases of Ordinary Shares on its behalf under the Programme, including during any closed period of the Company which may fall during the period of the Programme. The Programme will also be conducted in accordance with the provisions of the Market Abuse Regulation 596/2014/EU dealing with buy-back programmes as necessary.

 

Enquiries:

 

Franchise Brands plc

+44 (0) 1562 826705

Stephen Hemsley, Executive Chairman

Chris Dent, Chief Financial Officer

Julia Choudhury, Corporate Development Director

 

 

Allenby Capital Limited (Nominated Adviser and Joint Broker)

 

+44 (0) 203 328 5656

Jeremy Porter/ Liz Kirchner

 

 

Dowgate Capital Stockbrokers (Joint Broker)

 

+44 (0) 203 903 7715

James Serjeant / Colin Climie

 

 

MHP Communications (Financial PR)

+44 (0) 203 128 8100

Katie Hunt

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
POSGMGGMRFFGLZM
Date   Source Headline
25th Feb 20253:47 pmRNSHolding(s) in Company
20th Feb 20252:30 pmRNSCapital Markets Day
13th Feb 20257:00 amRNSAppointment of CFO and Group Finance Director
11th Feb 20257:00 amRNSDirector/PDMR Shareholding
7th Feb 20257:00 amRNS-RCapital Markets Day
31st Jan 20257:00 amRNSDirectors’ dealings
28th Jan 20257:00 amRNSTrading Update
16th Jan 20257:00 amRNSAppointment of Non-Executive Director
13th Nov 20242:00 pmRNSGrant of Options to director
12th Nov 20247:00 amRNSQ3 Trading Update
23rd Oct 20247:00 amRNSGroup CEO Appointment and Listing Consideration
15th Oct 20247:00 amRNSRe-commencement of Share purchase programme
23rd Sep 202411:54 amRNSHolding(s) in Company
20th Sep 20247:00 amRNSDirector/PDMR shareholding & holding in Company
17th Sep 20247:00 amRNSInterim Results
9th Sep 20247:00 amRNSNotice of Interim Results
30th Jul 20248:33 amRNSDirector/PDMR Shareholding
18th Jul 20241:55 pmRNSResult of AGM
18th Jul 20247:00 amRNSAGM Statement and Trading Update
8th Jul 20241:42 pmRNSGrant of Options
27th Jun 202410:01 amRNSAnnual General Meeting and proxy voting deadline
21st Jun 20244:40 pmRNSPublication of Annual Report and Accounts
20th Jun 20247:01 amRNSBoard and management changes
20th Jun 20247:00 amRNSFinal Results
3rd Jun 20247:00 amRNSTrading Update, Final Dividend & AGM
4th Apr 20243:02 pmRNSHolding(s) in Company
20th Feb 20242:45 pmRNSCapital Markets Day
18th Jan 20247:00 amRNSCapital Markets Day
18th Jan 20247:00 amRNSTrading Update
16th Jan 20245:12 pmRNSHolding(s) in Company
21st Nov 20237:00 amRNSInvestor presentation
15th Nov 20233:11 pmRNSHolding(s) in Company
25th Oct 20237:00 amRNSQ3 Trading Update
4th Sep 20237:00 amRNSBoard and management update
4th Aug 20237:00 amRNSDirector/PDMR Shareholding and Grant of Options
27th Jul 20237:01 amRNSAppointment of Chief Financial Officer
27th Jul 20237:00 amRNSInterim Results
25th Jul 20231:51 pmRNSInvestor Presentation via Investor Meet Company
5th Jul 20237:00 amRNSNotice of Interim Results
26th Jun 20237:00 amRNSShare Purchase Programme
1st Jun 20237:00 amRNSDirector/PDMR Shareholding
18th May 202310:10 amRNSHolding(s) in Company
10th May 20235:54 pmRNSGrant of options & director holdings
4th May 20237:00 amRNSInvestor Presentation
28th Apr 20235:00 pmRNSTotal Voting Rights
25th Apr 20234:09 pmRNSHolding(s) in Company
24th Apr 20231:55 pmRNSHolding(s) in Company
20th Apr 20239:33 amRNSResult of GM, Completion of Acquisition and TVR
18th Apr 20231:56 pmRNSResult of AGM
18th Apr 20237:00 amRNSAGM Statement and Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.